*Profit ex-items of $1.14/ shr tops estimates by 2 cts. *Continues to see 2013 earnings of $4.25 to $4.40 a share. Jan 23- U.S. orthopedic implant maker Stryker Corp on Wednesday reported fourth-quarter earnings excluding charges that exceeded analyst estimates as sales of its hip, knee and spine products improved.
Jan 18- Johnson& Johnson is negotiating a potential $2 billion settlement with patients who received its recalled artificial hip implant, Bloomberg News reported on Friday, citing five people familiar with the matter.
Jan 17- Medical device maker Stryker Corp said it will buy Hong Kong- based Trauson Holdings Co Ltd for $764 million in cash to expand in China, one of the fastest-growing markets for orthopaedic products. Founded in China in 1986, orthopaedics firm Trauson had sales of about $60 million in 2011 and makes spine devices and products for trauma surgeries.
Jan 17- Medical device maker Stryker Corp said it will buy Hong Kong- based Trauson Holdings Co Ltd for $764 million in an all cash deal, to expand in one of the fastest-growing markets for orthopaedic products in China. Stryker will pay HK $7.50 for every share of Trauson.
"Providers whose advertising does not provide adequate risk information are finding out today that the FDA is serious about consumer protection," said Steve Silverman, compliance director at FDA's Center for Devices and Radiological Health in a statement posted on the agency's website.
WASHINGTON, Dec 13- Fourteen U.S. states and the District of Columbia so far have told the federal government they plan to operate healthcare exchanges under President Barack Obama's reform law, leaving Washington with the daunting task of creating online marketplaces for at least two-thirds of the country.
Dec 12- Pfizer Inc will pay $55 million plus interest to settle charges that Wyeth promoted its acid reflux drug Protonix for unapproved uses and made unproven claims about the medicine, the U.S. Department of Justice said on Wednesday.
Dec 12- Pfizer Inc will pay $55 million plus interest to settle charges that Wyeth promoted its acid reflux drug Protonix for unapproved uses and made unproven claims about the medicine, the U.S. Department of Justice said on Wednesday.
*More competitors on horizon in Europe. Dec 4- Edwards Lifesciences Corp on Tuesday projected strong profit and sales growth in 2013, led by its Sapien artificial heart valve, which is implanted in a less-invasive procedure than traditional open-heart surgery.
NEW YORK, Nov 30- Blackstone Group LP has emerged as the frontrunner in an auction for Allscripts Healthcare Solutions Inc, but the companies remain far apart on price and a deal is highly uncertain, people familiar with the matter said.
*Medtronic, Pew want final rule adopted before Jan. 1. WASHINGTON, Nov 28- A major U.S. medical device maker and a leading public interest group are urging the U.S. government to move quickly to adopt a new rule requiring manufacturers to disclose their financial ties to physicians and teaching hospitals.
It was a complicated case, in part because the reform legislation itself was seriously flawed. The law’s drafters could have proposed a simpler and more efficient system, the New York Times reports.